ivosidenib,azacitidine
servier
['aml,(-streamline),(-seamless),(-kamloops),(-latamleaders)', 'aml,(-streamline),(-seamless),(-kamloops),(-dreamlike)', 'leukemia', 'myeloid', 'agile', 'servier']
today at #ash22 we presented findings from our phase 3 agile study in idh1-mutated acute myeloid leukemia (#aml). we are committed to continuing our research on behalf of patients living with this aggressive hematologic malignancy. learn more: 
Servier Pharmaceuticals is a U.S. subsidiary of Servier with a focus on oncology treatment and care. See our community guidelines here: https://t.co/tHNeTw4iGH